Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients
Recruiting
Phase 1
Interventional Study
Patients Undergoing External Dacrocystorhinostomy Operations
Assess Decreased Anesthetic Requirements Intraoperative
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 16 – 75
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 24 (estimated)
- Sponsor
- Research Institute of Ophthalmology, Egypt · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Assessing the intra and postoperative hemodynamic stability in patients undergoing external dacrocystorhinostomy under general anesthesia using Dexmedetomidine as a preoperative sedation compared to traditional technique with intraoperative analgesia and assessing decreased anesthetic requirements intra and postoperative
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
patients of both sexes 16 years to 75 years of age ASA (American society of Anesthesiologists) I-III
Exclusion Criteria:
* Pediatric age group
* ASA more than III
Contacts